ID   ZEC-145
AC   CVCL_VT86
DR   CCRID; 4201PAT-CCTCC00887
DR   Wikidata; Q98136468
RX   Patent=CN106011067A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201686.
CC   Population: Chinese.
CC   Doubling time: ~26 hours (Patent=CN106011067A).
ST   Source(s): Patent=CN106011067A
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 18,19,20
ST   D13S317: 14
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 14,14.2
ST   D21S11: 32.2
ST   D2S1338: 21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 14,19
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9
ST   Penta E: 11,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106011067A;
RA   Su D., Mao W.-M., Liu J.-S., Ying L.-S., Wu J.-Z.;
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106011067A, 12-Oct-2016.
//